Interpretation of Chinese expert consensus on diagnosis and treatment of upper urinary tract infection stones(2024 edition)
-
摘要: 上尿路感染性结石是由产脲酶病原微生物感染引起的上尿路结石，治疗的核心目标是清除结石和病原微生物、保护肾功能并减少复发。由中华医学会泌尿外科学分会感染与炎症学组、结石学组和激光学组共同撰写的《上尿路感染性结石诊断与治疗中国专家共识(2024版)》(后均简称《共识》)，旨在规范该疾病的诊治。本次共识解读对相关内容进行了更深入的说明与剖析，进一步明确了感染性结石的概念，对其发病机制、不同结石成分产生的原因进行更深入讨论；通过文献数据描述了不同病原微生物的临床检出情况；再次强调了该疾病临床表现没有典型特征，确诊需要通过结石成分分析；外科手术彻底清除结石、有效的抗菌药物治疗和密切的术后随访是治疗的核心要点，并对内科治疗的不同药物选择和副作用进行了详细的描述，与《共识》相辅相成，互为补充。Abstract: Upper urinary tract infection stones are caused by infection with urease producing pathogenic microorganisms. The core goal of treatment is to clear the stones and pathogenic microorganisms, protect kidney function and reduce recurrence. Aiming to standardize the diagnosis and treatment of infection stones, the "Chinese expert consensus on diagnosis and treatment of upper urinary tract infection stones(2024 edition)"(hereinafter referred to as the "consensus") were written by the Infection and Inflammation Group of the Chinese Urology Association(CUA), the Calculi Group of the CUA and the Laser Group of the CUA. This consensus interpretation provides a more in-depth explanation and analysis of the relevant content, further clarifying the concept of infection stones and discussing their pathogenic microorganisms and the reasons for the formation of different stone components. Clinical detection of the different pathogenic microorganisms was described through literature data. It was emphasized again that the clinical manifestations of this disease do not have typical features and diagnosis requires analysis of the composition of stones. The complete removal of stones through surgical procedures, adequate antibiotic treatment and close postoperative follow-up are the core points of treatment. Detailed discussions have been conducted on the selection of drugs and side effects for medical treatments, which complement the consensus.
-
Key words:
- upper urinary tract stones /
- infection stones /
- diagnosis /
- treatment /
- expert consensus /
- interpretation
-
-
[1] 麦海星, 乔庐东, 吴文起, 等. 上尿路感染性结石诊断与治疗中国专家共识(2024版)[J]. 微创泌尿外科杂志, 2024, 13(4): 217-223.
[2] Skolarikos A, Jung H, Neisius A, et al. EAU-guidelines on urolithiasis[OL]. Arnhem: European Association of Urology, 2024[2024-07-24].
https://uroweb.org/guidelines/urolithiasis [3] Marien T, Miller NL. Treatment of the infected stone[J]. Urol Clin North Am, 2015, 42(4): 459-472. doi: 10.1016/j.ucl.2015.05.009
[4] Hesse A, Heimbach D. Causes of phosphate stone formation and the importance of metaphylaxis by urinary acidification: a review[J]. World J Urol, 1999, 17(5): 308-315. doi: 10.1007/s003450050152
[5] Naber KJ, Scaeffer AJ, Heyns FH, et al. EAU-ICUD, Urogenital Infections[M]. Arnhem: European Association of Urology, 2010: 482-496.
[6] 丁西杰, 胡卫国, 李健, 等. 感染性结石患者尿病原菌与结石成分的关系[J]. 中华泌尿外科杂志, 2022, 43(10): 734-738. doi: 10.3760/cma.j.cn112330-20220901-00486
[7] de Cógáin MR, Lieske JC, Vrtiska TJ, et al. Secondarily infected nonstruvite urolithiasis: a prospective evaluation[J]. Urology, 2014, 84(6): 1295-1300. doi: 10.1016/j.urology.2014.08.007
[8] Marchini GS, Gebreselassie S, Liu XB, et al. Absolute Hounsfield unit measurement on noncontrast computed tomography cannot accurately predict struvite stone composition[J]. J Endourol, 2013, 27(2): 162-167. doi: 10.1089/end.2012.0470
[9] 黄健. 中国泌尿外科和男科疾病诊断治疗指南2022版[M]. 北京: 科学出版社, 2022: 394.
[10] 孙西钊. 医用冲击波[M]. 北京: 中国科学技术出版社, 2006: 812-816.
[11] Flannigan R, Choy WH, Chew B, et al. Renal struvite stones: pathogenesis, microbiology, and management strategies[J]. Nat Rev Urol, 2014, 11(6): 333-341. doi: 10.1038/nrurol.2014.99
[12] Wong C, Leveillee RJ. Single upper-pole percutaneous access for treatment of > or = 5-cm complex branched staghorn calculi: is shockwave lithotripsy necessary?[J]. J Endourol, 2002, 16(7): 477-481. doi: 10.1089/089277902760367430
[13] Chew BH, Reicherz A, Krambeck AE, et al. Prospective randomized trial of 2 versus 12-weeks of postoperative antibiotics after percutaneous nephrolithotomy in complex patients with infection-related kidney stones[J]. Int J Urol, 2022, 29(12): 1551-1558. doi: 10.1111/iju.15045
[14] 陈斌, 白培德. 负压技术在输尿管镜治疗上尿路结石应用的中国专家共识(2023年)[J]. 临床泌尿外科杂志, 2023, 38(8): 565-568. https://lcmw.whuhzzs.com/article/doi/10.13201/j.issn.1001-1420.2023.08.001
[15] Streem SB, Yost A, Dolmatch B. Combination "sandwich" therapy for extensive renal calculi in 100 consecutive patients: immediate, long-term and stratified results from a 10-year experience[J]. J Urol, 1997, 158(2): 342-345. doi: 10.1016/S0022-5347(01)64474-4
[16] Fontenelle LF, Sarti TD. Kidney stones: treatment and prevention[J]. Am Fam Physician, 2019, 99(8): 490-496.
[17] Siener R, Struwe F, Hesse A. Effect of L-methionine on the risk of phosphate stone formation[J]. Urology, 2016, 98: 39-43. doi: 10.1016/j.urology.2016.08.007
[18] Abou Chakra M, Dellis AE, Papatsoris AG, et al. Established and recent developments in the pharmacological management of urolithiasis: an overview of the current treatment armamentarium[J]. Expert Opin Pharmacother, 2020, 21(1): 85-96. doi: 10.1080/14656566.2019.1685979
[19] 高逢彬, 金讯波, 崔子连. 泌尿系感染性结石的成因及诊治现状[J/OL]. 泌尿外科杂志(电子版), 2015, 7(4): 51-54.
[20] 孙西钊, 吕建林, 叶章群. 泌尿系感染性结石的病因和诊治[J]. 中华泌尿外科杂志, 2010, 31(2): 141-143.
[21] Gonzalez RD, Whiting BM, Canales BK. The history of kidney stone dissolution therapy: 50 years of optimism and frustration with renacidin[J]. J Endourol, 2012, 26(2): 110-118. doi: 10.1089/end.2011.0380
[22] Wong HY, Riedl CR, Griffith DP. Medical management and prevention of struvite stones[M]. //Coe FL, Favus MJ, Pak CYC, et al. Kidney Stones: Medical and Surgical Mangement. Philadelphia: Lippincott-Raven, 1996: 941-950.
[23] Bichler KH, Eipper E, Naber K, et al. Urinary infection stones[J]. Int J Antimicrob Agents, 2002, 19(6): 488-498. doi: 10.1016/S0924-8579(02)00088-2
-
计量
- 文章访问数: 122
- 施引文献: 0
下载: